Actigraphic evidence for night-time hyperkinesia in Parkinson's disease

The International Journal of Neuroscience
Alexander Nass, Robert Daniel Nass

Abstract

Parkinson's disease is a common motor disorder that not only leads to motor symptoms but also autonomic dysregulation, mental changes, sensory disturbances, and sleep disorders such as increased daytime sleepiness and sleep fragmentation. The aim of this study was to find out how the daytime and night-time motor activity levels in individuals without motor disorders differ from patients with Parkinson's disease. Daytime and night-time motor activity levels in 17 PD patients and 69 controls were measured for three consecutive days and nights via actigraphy, a method of continuous long-term assessment of activity levels. A ratio between night-time and daytime motor activity was calculated. PD patients had a 1.5-2-fold lower daytime motor activity but also showed 1.5-2-fold higher motor activity at night time. Older controls showed a lower daytime but similar night-time motor activity when compared to younger controls. A ratio of night-time to daytime motor activity could clearly distinguish controls and patients. The possibility to distinguish patients and controls by the ratio of night-time to daytime motor activity is worth further investigation.

References

Jun 1, 1975·Electroencephalography and Clinical Neurophysiology·J Mouret
Sep 1, 1990·Journal of Neurology, Neurosurgery, and Psychiatry·J J Askenasy, M D Yahr
Jan 1, 1990·Movement Disorders : Official Journal of the Movement Disorder Society·S A FactorW J Weiner
Jan 1, 1990·Journal of Neural Transmission. General Section·J J Askenasy, M D Yahr
Mar 1, 1993·Acta Neurologica Scandinavica·J J Askenasy
Jan 9, 1998·IEEE Transactions on Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society·E J Van Someren
Jun 9, 1998·Journal of Neurology·F StocchiS Ruggieri
Oct 3, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Diego Garcia-BorregueroJuan A Pareja
Jan 18, 2003·Sleep Medicine Reviews·Avi Sadeh, Christine Acebo
Jan 18, 2003·Human Psychopharmacology·Neil Stanley
Feb 18, 2003·Fundamental & Clinical Pharmacology·Martin BaresIvan Rektor
Feb 18, 2003·Journal of Neural Transmission·J J M Askenasy
Mar 12, 2003·Sleep Medicine Reviews·Diego Garcia-BorregueroMauricio Bravo
Mar 26, 2003·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·P Denise, M L Bocca
May 17, 2003·Sleep·Sonia Ancoli-IsraelCharles P Pollak
Jun 5, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Sebastian PausUllrich Wüllner
Jun 5, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Matthew A BrodskyC Warren Olanow
Jul 17, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Birgit HöglClaudia Trenkwalder
Mar 23, 2004·Sleep Medicine·A AntoniniG Pezzoli
Apr 16, 2004·Nursing Research·Catherine A Warms, Basia L Belza
Feb 8, 2005·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·D KaynakO Uysal
Oct 26, 2005·Neurologic Clinics·Michael J Thorpy, Charles H Adler
Apr 8, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Juan Carlos Gómez-EstebanIker Bilbao
Jul 11, 2006·The Journal of Clinical Investigation·Joseph M SavittTed M Dawson
Oct 5, 2006·Journal of Neural Transmission. Supplementum·C L Comella
Oct 5, 2006·Journal of Neural Transmission. Supplementum·C HamaniA M Lozano
Mar 14, 2007·Parkinsonism & Related Disorders·Tjalf Ziemssen, Heinz Reichmann

❮ Previous
Next ❯

Citations

Feb 23, 2013·The International Journal of Clinical and Experimental Hypnosis·Gary ElkinsElmyra Encarnacion
Jul 10, 2010·The International Journal of Neuroscience·Jim BarnesKsenija Maravic
May 7, 2013·Sleep Medicine·Maartje LouterSebastiaan Overeem
Oct 28, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Elena UrrestarazuJulio Artieda
Mar 10, 2009·Current Neurology and Neuroscience Reports·Renee Monderer, Michael Thorpy
Feb 6, 2020·Journal of Dairy Science·C Alan RotzPeter J A Kleinman
May 11, 2016·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·L KlingelhoeferK R Chaudhuri
Apr 11, 2018·Frontiers in Neurology·Carlos J Madrid-NavarroM A Rol
Jan 15, 2019·Movement Disorders Clinical Practice·Jade Q WuAlice Cronin-Golomb
Aug 8, 2021·Parkinsonism & Related Disorders·Daniel J van WamelenUNKNOWN International Parkinson and Movement Disorder Society Non Motor Parkinson's Disease Study Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.